Novavax (NVAX) Misses Q3 EPS by 40c
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $10.22 -1.16%
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Basic and diluted net loss per share: -0.24
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($4.31), $0.40 worse than the analyst estimate of ($3.91). Revenue for the quarter came in at $178.8 million versus the consensus estimate of $334.62 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Concurrent Technologies (CNC:LN) PT Raised to GBP3.20 at Berenberg
- RBC Capital Reiterates Outperform Rating on Aviva PLC (AV:LN) (AVVIY)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
